Collectively, our data showed that high expression levels of COL4A1 are associated with pro-tumor effects via upregulation of the expression levels of immunosuppressive cytokines, thereby potentially affecting the poor prognosis of patients with LGG, PAAD, SKCM, and STAD. The gene discussed is COL4A1; the disease is pancreatic adenocarcinoma.